Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Management of Abdominal Aortic Aneurysms in 2021

Abdominal aortic aneurysms (AAA) are those of >3 cm aortic diameter.  They run the risk of rupture and ensuing death by bleeding. In consequence, they are treated to repair the aneurysm before it ruptures. 

Manejo de los aneurismas de aorta abdominal en 2021

In this regard, the most relevant predictor of rupture is aneurysm diameter. That is, the greater the aneurysm, the greater the risk. 

Randomized studies have not shown advantages in survival when <5.5 cm aneurysms were surgically treated vs. close observation. This evidence supports the use of 5.5 cm diameter as a cutoff value. Therefore, watching <5.5 cm aneurysms closely is safe and cost effective. 

Close observation, among other things, will detect aneurysms that might present accelerated sac growth (>1 cm in one year), even though we lack rigorous information to support intervention in this context. 

The key clinical points for AAA management in 2021 are:

  • Risk factors include advanced age, male sex, family history, smoking, hypercholesterolemia, and hypertension. Diabetics run the lowest risk. 
  • In men, AAA should be repaired when they are ≥5.5 cm diameter, and in women, when they are ≥5 cm.
  • Endovascular repair of AAA is associated with lower risk of perioperative complications and death vs. open surgery. 
  • The initial advantage of endovascular repair is kept for 2 or 3 years after procedure. There are no differences at long term in terms of death. 
  • Endovascular repair is associated to more reinterventions, in general simple procedures. Throughout patient life, open surgery is associated to more reinterventions due to laparotomy. 
  • For close observation, both CT and echocardiography are adequate.

Read also: TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC to TCT.


This is the most succinct information, and it is not much different from what have known for some time. Data are reassuring, seeing as they indicate we understand this disease, and thus we can take preventive action. 

Original Title: Management of Abdominal Aortic Aneurysms.

Reference: Andres Schanzer et al. N Engl J Med 2021;385:1690-8. DOI: 10.1056/NEJMcp2108504.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...